Show source-provided references
4. What is the impact of titanium particles and biocorrosion on implant survival and complications? A critical review
10.1111/clr.13305 ↗7. Phase stability and biological property evaluation of plasma sprayed hydroxyapatite coatings for orthopedic and dental applications
10.1016/j.actbio.2015.01.022 ↗9. Evaluation of fluorohydroxyapatite/strontium coating on titanium implants fabricated by hydrothermal treatment
10.1007/s40204-021-00162-7 ↗10. Kien, P., Quan, T., and Tuyet Anh, L. (2021). Coating Characteristic of Hydroxyapatite on Titanium Substrates via Hydrothermal Treatment. Coatings, 11.
10.3390/coatings11101226 ↗12. Fluorapatite ceramics for bone tissue regeneration: Synthesis, characterization and assessment of biomedical potential
10.1016/j.msec.2020.111211 ↗14. Surface modification of orthopedic implants by optimized fluorine-substituted hydroxyapatite coating: Enhancing corrosion behavior and cell function
10.1016/j.ceramint.2019.09.197 ↗17. (2005). Bruker-MicroCT MN074 Osteointegration: Analysis of Bone around a Metal Implant. Bruker-MicroCT Method Note, Bruker Micro-Ct Academy.
18. Fabrication of a biodegradable and cytocompatible magnesium/nanohydroxyapatite/fluorapatite composite by upward friction stir processing for biomedical applications
10.1016/j.jmbbm.2022.105137 ↗26. Slimen, J.B., Hidouri, M., Ghouma, M., Salem, E.B., and Dorozhkin, S.V. (2021). Sintering of Potassium Doped Hydroxy-Fluorapatite Bioceramics. Coatings, 11.
10.3390/coatings11070858 ↗27. Synthesis and characterization of hydroxyapatite, fluoride-substituted hydroxyapatite and fluorapatite
10.1023/A:1022975730730 ↗32. Comparative study of hydroxyapatite, fluor-hydroxyapatite and Si-substituted hydroxyapatite nanoparticles on osteogenic, osteoclastic and antibacterial ability
10.1039/C9RA00839J ↗33. Blanc-Sylvestre, N., Bouchard, P., Chaussain, C., and Bardet, C. (2021). Pre-Clinical Models in Implant Dentistry: Past, Present, Future. Biomedicines, 9.
10.3390/biomedicines9111538 ↗35. Peripheral quantitative computer tomographic, histomorphometric, and removal torque analyses of two different non-coated implants in a rabbit model
10.1111/j.1600-0501.2010.01980.x ↗37. Garbieri, T.F., Martin, V., dos Santos, C.F., Gomes, P.D.S., and Fernandes, M.H. (2021). The Embryonic Chick Femur Organotypic Model as a Tool to Analyze the Angiotensin II Axis on Bone Tissue. Pharmaceuticals, 14.
10.3390/ph14050469 ↗38. Francisco, I., Vale, F., Martin, V., Fernandes, M.H., and Gomes, P.S. (2021). From Blood to Bone—The Osteogenic Activity of L-PRF Membranes on the Ex Vivo Embryonic Chick Femur Development Model. Materials, 14.
10.3390/ma14247830 ↗39. A new ex vivo model of the bone tissue response to the hyperglycemic environment—The embryonic chicken femur organotypic culture in high glucose conditions
10.1016/j.bone.2022.116355 ↗40. 3D X-ray micro-computed tomography imaging for the microarchitecture evaluation of porous metallic implants and scaffolds
10.1016/j.micron.2020.102994 ↗41. Pajor, K., Pajchel, L., and Kolmas, J. (2019). Hydroxyapatite and Fluorapatite in Conservative Dentistry and Oral Implantology—A Review. Materials, 12.
10.3390/ma12172683 ↗43. Hydroxyapatite-coated oral implants: A systematic review and meta-analysis
44. Hydrothermal treatment of Ti surface to enhance the formation of low crystalline hydroxyl carbonate apatite
10.1186/s40824-014-0022-y ↗45. Direct growth of structurally controllable hydroxyapatite coating on Ti-6Al-4V through a rapid hydrothermal synthesis
10.1016/j.apsusc.2021.149672 ↗46. Biological responses of human osteoblasts and osteoclasts to flame-sprayed coatings of hydroxyapatite and fluorapatite blends
10.1016/j.actbio.2009.10.029 ↗47. Hydroxyapatite, fluor-hydroxyapatite and fluorapatite produced via the sol–gel method: Dissolution behaviour and biological properties after crystallisation
10.1007/s10856-013-5050-y ↗50. Phase segregation in hydroxyfluorapatite solid solution at high temperatures studied by combined XRD/solid state NMR
10.1039/C6RA17161C ↗54. Flouride Promotes Viability and Differentiation of Osteoblast-Like Saos-2 Cells Via BMP/Smads Signaling Pathway
10.1007/s12011-013-9770-0 ↗55. Fluoride decreased osteoclastic bone resorption through the inhibition of NFATc1 gene expression
10.1002/tox.21784 ↗56. Role of inhibition of osteogenesis function by Sema4D/Plexin-B1 signaling pathway in skeletal fluorosis in vitro
10.1007/s11596-015-1495-1 ↗57. A Morphological Study of the Effect of Fluoride on the Periodontium of the Hydrocortisone-Treated Rat
58. Non-endemic skeletal fluorosis: Causes and associated secondary hyperparathyroidism (case report and literature review)
10.1016/j.bone.2021.115839 ↗60. Recent advances in cellular effects of fluoride: An update on its signalling pathway and targeted therapeutic approaches
10.1007/s11033-021-06523-6 ↗61. The status of citrate in the hydroxyapatite/collagen complex of bone; and Its role in bone formation
10.7243/2050-1218-3-4 ↗62. Morganti, C., Bonora, M., Marchi, S., Ferroni, L., Gardin, C., Wieckowski, M.R., Giorgi, C., Pinton, P., and Zavan, B. (2020). Citrate Mediates Crosstalk between Mitochondria and the Nucleus to Promote Human Mesenchymal Stem Cell In Vitro Osteogenesis. Cells, 9.
10.3390/cells9041034 ↗